Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Korean Journal of Perinatology ; : 190-199, 2015.
Artículo en Coreano | WPRIM | ID: wpr-97438

RESUMEN

PURPOSE: Hypertensive disorders of pregnancy increase morbidity and mortality of fetus and neonates. Recently some studies revealed that antihypertensive agents affected the neonatal outcomes. The aim of this study was to investigate the prognosis of preterm infants delivered from the mothers with hypertensive disorders who were treated with antihypertensive agents and magnesium sulfate. METHODS: This retrospective study was conducted on preterm infants who were delivered from normotensive mother (control, n=436) and antihypertensive drugs +/- magnesium sulfate treated mother (study, n=150) between January 2009 and December 2013. Study group were divided into two groups based on whether they received antihypertensive drugs only (n=110) and additional magnesium sulfate (n=40). We compared the characteristics of mothers and neonatal outcomes. RESULTS: Study group had shorter gestational age (32.2+/-3.5 weeks vs. 33.7+/-3.0 weeks, P=0.000) and lower birth weight (1,810.5 +/- 689.2 g, 2,212.1 +/- 604.9 g, P=0.000), and higher rate of small for gestational age infants (22% vs 11%, P=0.000). One minute and 5 minutes Apgar score were lower, but duration of hospital days, oxygen supplement and mechanical ventilation were longer in study group. Respiratory distress syndrome, bronchopulmonary dysplasia, patent ductus arteriosus, retinopathy of prematurity, intraventricular hemorrhage occurred more in study group than control. The group treated with magnesium sulfate together with antihypertensive agent had lower 1 minute and 5 minutes Apgar score than the group taken antihypertensive agent only. CONCLUSIONS: Mothers with hypertensive disorders have increased the risk of preterm delivery, low birth weight, and high neonatal morbidity rate. Therefore it is important to predict and manage possible complication. Moreover, if magnesium sulfate is taken, careful neonatal monitoring is needed because of possible low Apgar score.


Asunto(s)
Humanos , Lactante , Recién Nacido , Embarazo , Antihipertensivos , Puntaje de Apgar , Peso al Nacer , Displasia Broncopulmonar , Conducto Arterioso Permeable , Feto , Edad Gestacional , Hemorragia , Recién Nacido de Bajo Peso , Recien Nacido Prematuro , Sulfato de Magnesio , Mortalidad , Madres , Oxígeno , Pronóstico , Respiración Artificial , Retinopatía de la Prematuridad , Estudios Retrospectivos
2.
Neonatal Medicine ; : 233-237, 2015.
Artículo en Coreano | WPRIM | ID: wpr-198023

RESUMEN

Wolf-Hirschhorn syndrome is a congenital disorder associated with partial deletion of the short arm of chromosome 4. The majority of patients showed characteristic facial anomalies - so called "Greek-Helmet" appearances - mental retardation, growth retardation, and developmental delay. Here we report the case of a 3-year-old girl who was diagnosed as having Wolf-Hirschhorn syndrome immediately at birth with distinct facial anomalies and an abnormal chromosomal karyotype [46,XX,del(4)(p14)]. The patient later presented with status epilepticus and magnetic resonance imaging showed periventricular nodular heterotopia.


Asunto(s)
Preescolar , Femenino , Humanos , Brazo , Cromosomas Humanos Par 4 , Enfermedades y Anomalías Neonatales Congénitas y Hereditarias , Discapacidad Intelectual , Cariotipo , Imagen por Resonancia Magnética , Parto , Heterotopia Nodular Periventricular , Estado Epiléptico , Síndrome de Wolf-Hirschhorn
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA